Yuan-Yuan Li1, Reza Ghanbari1,2, Wimal Pathmasiri1, Susan McRitchie1, Hossein Poustchi2, Amaneh Shayanrad2, Gholamreza Roshandel3, Arash Etemadi4, Jonathan D Pollock5, Reza Malekzadeh2, Susan C J Sumner1. 1. Department of Nutrition, Nutrition Research Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. 2. Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Science, Tehran, Iran. 3. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran. 4. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States. 5. Genetics, Epigenetics, and Developmental Neuroscience Branch, National Institute on Drug Abuse, Bethesda, MD, United States.
Abstract
Objective: Over 50 million people worldwide are estimated to use opioids, of which ~30 million use opiates (opium and its derivatives). Use of opiates has been associated with a variety of adverse complications such as neurological and behavioral outcomes, addiction, cancers, diabetes, and cardiovascular disease. While it is well known that opiates exert their neurobiological effects through binding with mu, kappa, and delta receptors to exert analgesic and sedative effects, mechanistic links to other health effects are not well understood. Our study focuses on the identification of biochemical perturbations in Golestan Cohort Study (GCS) opium users. Methods: We used untargeted metabolomics to evaluate the metabolic profiles of 218 opium users and 80 non-users participating in the GCS. Urine samples were obtained from adult (age 40-75) opium users living in the Golestan Province of Iran. Untargeted analysis of urine was conducted using a UPLC-Q-Exactive HFx Mass Spectrometry and a 700 MHz NMR Spectrometry. Results: These GCS opium users had a significantly higher intake of tobacco and alcohol and a significantly decreased BMI compared with non-users. Metabolites derived from opium (codeine, morphine, and related glucuronides), nicotine, and curing or combustion of plant material were increased in opium users compared with non-users. Endogenous compounds which differentiated the opium users and non-users largely included vitamins and co-factors, metabolites involved in neurotransmission, Kreb's cycle, purine metabolism, central carbon metabolism, histone modification, and acetylation. Conclusions: Our study reveals biochemical perturbations in GCS opium users that are important to the development of intervention strategies to mitigate against the development of adverse effects of substance abuse.
Objective: Over 50 million people worldwide are estimated to use opioids, of which ~30 million use opiates (opium and its derivatives). Use of opiates has been associated with a variety of adverse complications such as neurological and behavioral outcomes, addiction, cancers, diabetes, and cardiovascular disease. While it is well known that opiates exert their neurobiological effects through binding with mu, kappa, and delta receptors to exert analgesic and sedative effects, mechanistic links to other health effects are not well understood. Our study focuses on the identification of biochemical perturbations in Golestan Cohort Study (GCS) opium users. Methods: We used untargeted metabolomics to evaluate the metabolic profiles of 218 opium users and 80 non-users participating in the GCS. Urine samples were obtained from adult (age 40-75) opium users living in the Golestan Province of Iran. Untargeted analysis of urine was conducted using a UPLC-Q-Exactive HFx Mass Spectrometry and a 700 MHz NMR Spectrometry. Results: These GCS opium users had a significantly higher intake of tobacco and alcohol and a significantly decreased BMI compared with non-users. Metabolites derived from opium (codeine, morphine, and related glucuronides), nicotine, and curing or combustion of plant material were increased in opium users compared with non-users. Endogenous compounds which differentiated the opium users and non-users largely included vitamins and co-factors, metabolites involved in neurotransmission, Kreb's cycle, purine metabolism, central carbon metabolism, histone modification, and acetylation. Conclusions: Our study reveals biochemical perturbations in GCS opium users that are important to the development of intervention strategies to mitigate against the development of adverse effects of substance abuse.
Authors: Deborah Randall; Louisa Degenhardt; Claire M Vajdic; Lucy Burns; Wayne D Hall; Matthew Law; Tony Butler Journal: Aust N Z J Public Health Date: 2011-03-07 Impact factor: 2.939
Authors: Arash Etemadi; Hossein Poustchi; Antonia M Calafat; Benjamin C Blount; Victor R De Jesús; Lanqing Wang; Akram Pourshams; Ramin Shakeri; Maki Inoue-Choi; Meredith S Shiels; Gholamreza Roshandel; Gwen Murphy; Connie S Sosnoff; Deepak Bhandari; Jun Feng; Baoyun Xia; Yuesong Wang; Lei Meng; Farin Kamangar; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh; Neal D Freedman Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-01-08 Impact factor: 4.254
Authors: Steven G Carmella; Menglan Chen; Yan Zhang; Siyi Zhang; Dorothy K Hatsukami; Stephen S Hecht Journal: Chem Res Toxicol Date: 2007-06-09 Impact factor: 3.739
Authors: David Broadhurst; Royston Goodacre; Stacey N Reinke; Julia Kuligowski; Ian D Wilson; Matthew R Lewis; Warwick B Dunn Journal: Metabolomics Date: 2018-05-18 Impact factor: 4.290
Authors: B R Rushing; S McRitchie; L Arbeeva; A E Nelson; M A Azcarate-Peril; Y-Y Li; Y Qian; W Pathmasiri; S C J Sumner; R F Loeser Journal: Osteoarthritis Cartilage Date: 2021-10-28 Impact factor: 6.576
Authors: Elke Anklam; Martin Iain Bahl; Robert Ball; Richard D Beger; Jonathan Cohen; Suzanne Fitzpatrick; Philippe Girard; Blanka Halamoda-Kenzaoui; Denise Hinton; Akihiko Hirose; Arnd Hoeveler; Masamitsu Honma; Marta Hugas; Seichi Ishida; George En Kass; Hajime Kojima; Ira Krefting; Serguei Liachenko; Yan Liu; Shane Masters; Uwe Marx; Timothy McCarthy; Tim Mercer; Anil Patri; Carmen Pelaez; Munir Pirmohamed; Stefan Platz; Alexandre Js Ribeiro; Joseph V Rodricks; Ivan Rusyn; Reza M Salek; Reinhilde Schoonjans; Primal Silva; Clive N Svendsen; Susan Sumner; Kyung Sung; Danilo Tagle; Li Tong; Weida Tong; Janny van den Eijnden-van-Raaij; Neil Vary; Tao Wang; John Waterton; May Wang; Hairuo Wen; David Wishart; Yinyin Yuan; William Slikker Journal: Exp Biol Med (Maywood) Date: 2021-11-16
Authors: Jaspreet Sharma; Blake R Rushing; Madeline S Hall; Kristi L Helke; Susan L McRitchie; Natalia I Krupenko; Susan J Sumner; Sergey A Krupenko Journal: Metabolites Date: 2022-05-18